Novo Nordisk CEO steps down amid market challenges, including competition from Eli Lilly's rival drug and setbacks with Novo Nordisk's obesity treatments.
US considers controversial plan to relocate Palestinians from Gaza to unstable Libya
Moody's downgrades US credit rating over rising debt, signaling broader market concerns about the nation's fiscal trajectory.
Novo Nordisk CEO steps down amid market challenges, including competition from Eli Lilly's rival drug and setbacks with Novo Nordisk's obesity treatments.
US considers controversial plan to relocate Palestinians from Gaza to unstable Libya
Moody's downgrades US credit rating over rising debt, signaling broader market concerns about the nation's fiscal trajectory.